Mellanby Course 2018: Diagnostic Tests for Osteoporosis

If you work in the field of osteoporosis or other metabolic bone diseases, then register now to attend one or both days of this unique biennial course.

Clinical Use of Bone Turnover Markers

Course Overview: 

Bone Turnover Markers (BTM) have long been used as diagnostic tests for metabolic bone diseases. In the past 20 years, markers that are more specific to bone have been introduced and have been found to be useful in osteoporosis, particularly for monitoring treatment. This course provides a background to the clinical use of bone turnover markers. 

Target Audience: 

This day-long course is open to clinicians (eg. endocrinology, rheumatology, care of the elderly and clinical chemistry), radiographers, radiologists, assistant practitioners, laboratory scientists and nurses involved in the clinical management of patients at risk of osteoporotic fractures. 


13th June 2018

Eventbrite - Mellanby Course: Diagnostic tests for osteoporosis

Identification of Vertebral Fracture

Course Overview: 

Up to one in five older people will have vertebral fracture, but most are unaware of this. Such fractures can be diagnosed by spinal radiographs but more recently, the bone densitometer has been used for this purpose: vertebral fracture assessment. The use of this technique is increasing worldwide; this course gives a basic training on the identification of vertebral fractures. 


Target audience: 

This day-long course is open to clinicians, scan technicians,  radiographers, radiologists, assistant practitioners and nurses involved in developing and delivering fracture risk assessment services.


14th June 2018

Eventbrite - Mellanby Course: Diagnostic tests for osteoporosis

Useful Dates

  • Early bird closes: 6th April 2018
  • Registration closes: 12th May 2018

Endorsement, support and CPD

Approved by the Royal College of Physicians. 6 CPD points are available per day.

Approved by the British Institute of Radiology.

Endorsed by the College of Radiographers and may help to support outcomes 2, 3, 9, 18 and 19 of CPD Now.



Sponsored by: 


Sponsored by Internis and Roche